CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis
Frontiers in Bioengineering and Biotechnology · 24.09.2025 · 13
DOI: 10.3389/fbioe.2025.1641476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 24.09.2025. Verfasst von Yimurang Hamiti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Distraction osteogenesis (DO) represents a promising approach for treating large bone defects, yet prolonged consolidation periods limit clinical efficacy, and the molecular mechanisms underlying neuropeptide regulation of bone regeneration remain poorly understood. We systematically investigated calcitonin gene-related peptide (CGRP)-dependent molecular signaling effects on rat bone marrow mesenchymal stem cells (BMSCs) through comprehensive in vitro analyses and evaluated therapeutic efficacy in a rat femoral DO model (n = 108). CGRP (10 −8 M) significantly enhanced BMSC proliferation, migration, and osteogenic differentiation while reducing apoptosis by 47%. Molecular analysis revealed rapid cyclic adenosine monophosphate (cAMP) elevation (2.3-fold within 30 min) and subsequent PKA/CREB pathway activation, upregulating key osteogenic genes ( Runx2 , Sp7 , Spp1 , and Bglap ). The CGRP receptor antagonist and the PKA inhibitor completely abolished these effects, confirming pathway dependence. In vivo , local CGRP treatment accelerated bone formation, improving bone mineral density (1.8-fold), trabecular microarchitecture, and biomechanical properties, including ultimate load (89% increase) and stiffness (76% increase), compared to controls. These findings demonstrate that CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis through cAMP/PKA/CREB activation, providing mechanistic insights into neuropeptide regulation of bone regeneration and identifying CGRP as a promising therapeutic target for optimizing distraction osteogenesis outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Trauma and Microreconstructive Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Xinjiang Key Laboratory of Trauma Repair and Reconstruction, Urumqi, Xinjiang, China.
Zitieren
APA
Hamiti, Y., Liu, K., Wang, S., Yang, X., Kadier, X., & Yusufu, A. (2025). CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1641476
Vancouver
Hamiti Y, Liu K, Wang S, Yang X, Kadier X, Yusufu A. CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1641476
BibTeX
@article{Hamiti2025,
author = {Hamiti, Yimurang and Liu, Kai and Wang, Sulong and Yang, Xin and Kadier, Xiriaili and Yusufu, Aihemaitijiang},
title = {CGRP-dependent molecular signaling drives bone marrow stem cell osteogenesis in distraction osteogenesis},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2025},
volume = {13},
doi = {10.3389/fbioe.2025.1641476}
}
EUVIMED